The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

MeSH terms

• Arthritis, Rheumatoid / drug therapy
• Azetidines / adverse effects
• Azetidines / therapeutic use
• Betacoronavirus
• COVID-19
• Colitis, Ulcerative / drug therapy
• Coronavirus Infections / complications*
• Cytokines
• Dermatitis, Atopic / drug therapy
• Heterocyclic Compounds, 3-Ring / adverse effects
• Heterocyclic Compounds, 3-Ring / therapeutic use
• Humans
• Immunomodulation*
• Janus Kinases / antagonists & inhibitors*
• Nitriles
• Pandemics
• Piperidines / adverse effects
• Piperidines / therapeutic use
• Pneumonia, Viral / complications*
• Primary Myelofibrosis / drug therapy
• Purines
• Pyrazoles / adverse effects
• Pyrazoles / therapeutic use
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use
• Pyrroles / adverse effects
• Pyrroles / therapeutic use
• Randomized Controlled Trials as Topic
• SARS-CoV-2
• STAT Transcription Factors
• Sulfonamides / adverse effects
• Sulfonamides / therapeutic use